Pfizer: Guidance Reaffirmed, Nice Yield. What's Not To Like?

Pfizer Inc. recently released its full-year 2025 guidance and reaffirmed its 2024 outlook, aligning with Street expectations. It seems having faith in the company may have paid off.

Free stock photo of analysis, biochemistry, biology

Image Source: Unsplash

Pfizer Inc. (PFE) recently released its full-year 2025 guidance and reaffirmed its 2024 outlook, aligning with Street expectations. Not that I had any doubt, but boy am I glad to see my faith in the company is well-placed, observes Keith Fitz-Gerald, editor of 5 With Fitz.

Pfizer anticipates 2025 revenue to range between $61 billion and $64 billion, with adjusted, diluted earnings per share projected at $2.80 to $3, compared to consensus estimates of $63.28 billion and $2.88, respectively.


Pfizer Inc. (PFE) Stock Chart

chart

Talk about an opportunity. Pfizer sits squarely at the nexus of two major themes unfolding right in front of us: customizable medicine and AI. Meanwhile, I’m loving the dividends.

Many investors bail when a stock they own falters. But sticking with them can make a huge difference in your portfolio over time. Dividend-paying stocks tend to fall less, stabilize first, and provide superior performance over time versus their non-dividend paying cousins. Dividend growers, especially. 


About the Author

 Keith Fitz-Gerald has been called “somebody you should pay attention to” by #1 New York Times bestselling author and personal finance expert Suze Orman, “always insightful” by Constellation Research CEO Ray Wang, and a “market visionary” by Forbes. He has more than 3,000 prime-time appearances to his credit on the Fox Business Network, CNBC, Dubai One, BBC, and other networks around the world. 

Mr. Fitz-Gerald’s commentary and market analysis have been featured in such notable publications as the Wall Street JournalThe Times (of London), Wired, and more. He is the principal of the Fitz-Gerald Group which provides consulting services to professional wealth managers. and personally writes the popular, free 5 with Fitz read by tens of thousands of individual investors, financial advisors, and hedge fund pros around the world daily.

Mr. Fitz-Gerald believes anybody can be wildly successful in the financial markets when armed with the right knowledge, education, and tactics. 


More By This Author:

EQT Corporation: A Natural Gas-Weighted Stock Ideal For A More Disciplined Energy Industry
S&P 500: New Highs, Yes. But Weaker Internals Suggest Caution
Kohl’s: An Interesting, Speculative Play In The Retail Sector

STOCKS IN THIS ARTICLE

Comments